Home » Baxter Warning Letter Sprinkled With Repeat Observations
Baxter Warning Letter Sprinkled With Repeat Observations
Baxter Healthcare landed an FDA warning letter that includes multiple repeat observations and issues related to test methods, CAPAs and over-infusion with its elastomeric infusion systems.
Devices & Diagnostics Letter
Devices Inspections and Audits Regulatory AffairsDevices & Diagnostics Letter
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May